Clinical Evidence Regarding Spermidine–Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management
<b>Background:</b> Vestibulodynia (VBD) represents a summation and overlapping of trigger factors (infections, hormonal disturbances, allergies, genetic aspects, psychological vulnerability, and others) with broad individual variability. As there are no standard treatment options for VBD...
Saved in:
| Main Authors: | Filippo Murina, Alessandra Graziottin, Nicla Toni, Maria Teresa Schettino, Luca Bello, Alessandra Marchi, Barbara Del Bravo, Dania Gambini, Lara Tiranini, Rossella Elena Nappi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/11/1448 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulvodynia – a multidisciplinary problem
by: K. R. Bakhtiyarov, et al.
Published: (2020-04-01) -
Combining Acmella oleracea and Boswellia serrata extracts: a novel pharmacological approach in inflammatory vestibulodynia
by: Antimo Fusco, et al.
Published: (2024-12-01) -
Spermidine cures yeast of prions
by: Shaun H. Speldewinde, et al.
Published: (2015-12-01) -
Study on the effects of spermidine on LPS-induced inflammatory osteolysis in mouse calvaria
by: ZHAO Xinyu, et al.
Published: (2025-06-01) -
Spermidine alleviates thymopoiesis defects and aging of the peripheral T-cell population in mice after radiation exposure
by: Kengo Yoshida, et al.
Published: (2025-01-01)